<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-859
Date of Submission: 2025-05-10

This report was submitted by a Other Healthcare Professional from Lewis-Campbell Medical Center concerning patient ANON-PX-2302. The subject is a 30-year-old male with a significant medical history including atrial fibrillation, seasonal allergies, hypertension, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole (Proton-pump inhibitor) administered via the Intramuscular route at a dosage of 271mg, initiated on 2025-02-15 for Gastroesophageal reflux disease and discontinued on 2025-05-08; Ibuprofen administered via the Intramuscular route at a dosage of 55mg, initiated on 2025-02-15 for Pain and inflammation and discontinued on 2025-05-08.

On approximately 2025-03-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Dizziness. The Maculopapular Rash was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed garden and advised society. The current patient status regarding this symptom is 'Unknown'. The Dizziness was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Top age central without place. I probably outside watch yard think.</data>
report_id: ADR-2025-859
report_date: '2025-05-10'
patient_details:
  patient_id: ANON-PX-2302
  gender: Male
  relevant_history:
  - atrial fibrillation
  - seasonal allergies
  - hypertension
  - anxiety
  age_at_reaction: 30
suspected_drugs:
- drug_name: Omeprazole
  dosage: 271mg
  route_of_administration: Intramuscular
  start_date: '2025-02-15'
  indication_for_use: Gastroesophageal reflux disease
  drug_class: Proton-pump inhibitor
  end_date: '2025-05-08'
- drug_name: Ibuprofen
  dosage: 55mg
  route_of_administration: Intramuscular
  start_date: '2025-02-15'
  indication_for_use: Pain and inflammation
  end_date: '2025-05-08'
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2025-03-18'
  severity: Severe
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed garden and advised society.
- symptom_name: Dizziness
  onset_date: '2025-03-18'
  severity: Severe
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 9
reporting_facility: Lewis-Campbell Medical Center
reporter_type: Other Healthcare Professional
notes: Top age central without place. I probably outside watch yard think.
